Gemelli Biotech
No Lab Visits. No Appointments. Just Answers.
- Business Model
- B2C
- Website
- gemellibiotech.com
- Total Funding
- $19.0M
- Last Round
- $19.0M Series AJun 2022
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Gemelli Biotech develops at-home precision diagnostics for gastrointestinal symptoms and microbiome-related conditions. Its breath and capillary blood tests help patients investigate causes of bloating, abdominal pain, diarrhea, constipation, and post-infectious bowel symptoms without a laboratory visit or appointment. Customers collect samples at home, return them to the laboratory, receive results electronically, and can share the findings with healthcare providers.
Summary
Gemelli Biotech is a Biotech company. It has raised $19.0M in total across 1 round, most recently a $19.0M Series A round in Jun 2022.
Funding History
Jun 2022
Similar Companies
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/gemelli-biotech"><img src="https://indexed.vc/api/badge/company/gemelli-biotech" alt="Gemelli Biotech on Indexed.vc" width="260" height="76" /></a>